tiprankstipranks
Trending News
More News >

Richard Peters Insider Profile

4 Followers
Richard Peters, President & CEO, Director at Merrimack Pharmaceuticals, holds ― shares in Merrimack Pharmaceuticals (Ticker: MACK), holds 2.07K shares in Aprea Therapeutics (Ticker: APRE), holds 88.10K shares in Kineta (Ticker: KANT). Most recently, Richard Peters ― shares of Merrimack Pharmaceuticals on ― for an estimated value of ―.
tipranks
Richard Peters

Richard Peters
Merrimack Pharmaceuticals (MACK)
President & CEO, Director

Ranked #41,360 out of 100,956 Corporate Insiders

Profitable Transactions

67%
2 out of 3 Profitable Transactions

Average Return

+5.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$36K
86.45%
13.55%
A breakdown of Richard Peters's holdings

Insider Roles

Kineta
(KANT)
Director
Aprea Therapeutics
(APRE)
Director
Roles that Richard Peters holds in companies

Most Profitable Insider Trade

Stock:
Kineta
(KANT)
Rating:Informative Sell
Date:Jul 06, 2022 - Jul 06, 2023
Return:+24.60%
The most profitable trade made by Richard Peters

Richard Peters's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
MACK
Merrimack Pharmaceuticals
Aprea Therapeutics
Jun 21, 2024
Director
Uninformative Buy
$4.83K
Kineta
Dec 20, 2022
Director
Uninformative Sell
3.59K
$30.83K
List of latest transactions for each holding click on a transaction to see Richard Peters's performance on stock

Richard Peters insider profile FAQ

What is the percentage of profitable transactions made by Richard Peters?
The percentage of profitable transactions made by Richard Peters is 67%.
    What is the average return per transaction made by Richard Peters?
    The average return per transaction made by Richard Peters is 5.00%.
      What stocks does Richard Peters hold?
      Richard Peters holds: MACK, APRE, KANT stocks.
        What was Richard Peters’s latest transaction?
        Richard Peters latest transaction was an Uninformative Buy of ―.
          What was Richard Peters's most profitable transaction?
          Richard Peters’s most profitable transaction was an Informative Sell of KANT stock on July 6, 2022. The return on the trade was 24.60%.
            What is Richard Peters's role in Merrimack Pharmaceuticals?
            Richard Peters's role in Merrimack Pharmaceuticals is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.